CARsgen Presents First Clinical Data on Its In Vivo CAR-T Product Candidate CT1182
1 hour ago
SHANGHAI, Nov. 22, 2026 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on developing innovative CAR T-cell therapies, announces the clinical data from CT1182 (KJ-C2529), a CD19/CD20-targeting in vivo CAR T-cell product candidate developed on...
...Read the fullstory
It's better on the More. News app
✅ It’s fast
✅ It’s easy to use
✅ It’s free
More. from PR Newswire ⬇️

